FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:421-423 January 25, 2007 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Palareti, G. PubMed Citation

To the Editor: In the PROLONG study, Palareti et al. (Oct. 26 issue)¹ conclude that patients with an abnormal D-dimer test 1 month after the discontinuation of anticoagulation therapy have a significantly increased incidence of recurrent venous thromboembolism. However, it is unclear whether this observation is valid regardless of age, despite the adjusted multivariable analysis performed by the authors. Indeed, patients with an abnormal D-dimer test were much older (mean [±SD] age, 69.7±13.0 years) than those with a normal D-dimer test (59.3±16.2). Therefore, 74% of patients with an abnormal D-dimer test were older than 65. In this subgroup, the rate . . . [Full Text of this Article]

This article has been cited by other articles:

• Wu, H., Birmingham, D. J., Rovin, B., Hackshaw, K. V., Haddad, N., Haden, D., Yu, C.-Y., Hebert, L. A. (2008). D-Dimer Level and the Risk for Thrombosis in Systemic Lupus Erythematosus. CJASN 3: 1628-1636 [Abstract] [Full Text]